Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
219.58Prev. Close
219.10Volume
0Total traded value
NAUpper Circuit
262.92Lower Circuit
175.28Fundamentals
| Market Cap | ₹5,515Cr |
| ROE | 3.16% |
| P/E Ratio(TTM) | 135.22 |
| EPS(TTM) | 1.62 |
| P/B Ratio | 7.83 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.36 |
| Book Value | 27.99 |
| Debt to Equity | 0.68 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Sequent Scientific
SeQuent Scientific Limited is India's premier animal health company, offering a portfolio of pharmaceutical ingredients and finished drugs for global veterinary care. The company's vision is to be a leading integrated animal health company, committed to providing quality veterinary solutions across the world through its brand Alivira. With a strong international footprint, the company is proudly positioned among the top 25 animal health companies worldwide.;
| Parent Organisation | Sequent Scientific |
| Managing Director | Mr. Rajaram Narayanan |
| NSE Symbol | SEQUENT |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(2)
| FUND NAME | AUM(%) |
|---|---|
| UTI Healthcare Fund Direct Growth | 1.48% |
| Quant Small Cap Fund Direct Plan Growth | 1.43% |
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 86.25 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.80 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.65 | ||
| Wockhardt | NA (0.00%) | -434.71 |